| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $4.30B | -5.3% |
| Gross Profit | $1.78B | +3.4% |
| R&D Expense | $287.2M | +2.3% |
| SG&A Expense | $155.1M | +24.4% |
| Operating Income | $587.3M | +28.1% |
| Pre-tax Income | $621.6M | +34.1% |
| Income Tax | $9.5M | -90.4% |
| Net Income | $612.1M | +67.9% |
| EPS (Basic) | $3.90 |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.52B | +32.4% |
| Accounts Receivable | $541.7M | -14.1% |
| Inventory | $422.5M | -38.1% |
| Current Assets | $2.63B | +1.0% |
| Total Assets | $3.60B | +1.2% |
| Current Liabilities | $1.09B | +3.4% |
| Total Liabilities | $1.37B | +5.2% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.15B | +114.4% |
| Capital Expenditures | $55.9M | -39.5% |
| Investing Cash Flow | -$70.3M | +33.5% |
| Financing Cash Flow | -$690.2M | -18.3% |
| Free Cash Flow | $1.09B | +146.6% |
| +73.3% |
| EPS (Diluted) | $3.87 | +73.5% |
| Stockholders' Equity |
| $2.23B |
| -1.1% |